These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6695616)

  • 1. Disorders of verbal expression in parkinsonism.
    Streifler M; Hofman S
    Adv Neurol; 1984; 40():385-93. PubMed ID: 6695616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysarthrophonia of Parkinson syndrome].
    Ackermann H; Ziegler W
    Fortschr Neurol Psychiatr; 1989 Apr; 57(4):149-60. PubMed ID: 2656448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
    Ramig LO; Fox C; Sapir S
    Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parkinsonian dysarthria].
    Gentil M; Pollak P; Perret J
    Rev Neurol (Paris); 1995 Feb; 151(2):105-12. PubMed ID: 7676137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speech treatment for Parkinson's disease.
    Trail M; Fox C; Ramig LO; Sapir S; Howard J; Lai EC
    NeuroRehabilitation; 2005; 20(3):205-21. PubMed ID: 16340101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple system atrophy speech assessment: study of five cases].
    Knopp DB; Barsottini OG; Ferraz HB
    Arq Neuropsiquiatr; 2002 Sep; 60(3-A):619-23. PubMed ID: 12244402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall intelligibility, language, articulation, voice and resonance characteristics in a child with Shprintzen-Goldberg syndrome.
    Van Lierde KM; Mortier G; Loeys B; Baudonck N; De Ley S; Marks LA; Van Borsel J
    Int J Pediatr Otorhinolaryngol; 2007 May; 71(5):721-8. PubMed ID: 17303258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life with communication changes in Parkinson's disease.
    Miller N; Noble E; Jones D; Burn D
    Age Ageing; 2006 May; 35(3):235-9. PubMed ID: 16540492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speech dysfunction in early Parkinson's disease.
    Stewart C; Winfield L; Hunt A; Bressman SB; Fahn S; Blitzer A; Brin MF
    Mov Disord; 1995 Sep; 10(5):562-5. PubMed ID: 8552106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voice analysis and videolaryngostroboscopy in patients with Parkinson's disease.
    Yücetürk AV; Yilmaz H; Eğrilmez M; Karaca S
    Eur Arch Otorhinolaryngol; 2002 Jul; 259(6):290-3. PubMed ID: 12115074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A protocol for the evaluation of the voice and speech of the hearing impaired].
    Ormezzano Y; Mesley A; Descourtieux C
    Rev Laryngol Otol Rhinol (Bord); 2001; 122(5):311-7. PubMed ID: 12092501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Voice and speech problems in Parkinson's disease].
    Artzi T; Yaretzky A
    Harefuah; 1989 Dec; 117(11):396-9. PubMed ID: 2620881
    [No Abstract]   [Full Text] [Related]  

  • 13. The contribution of apraxic speech to working memory deficits in Parkinson's disease.
    Howard LA; Binks MG; Moore AP; Playfer JR
    Brain Lang; 2000 Sep; 74(2):269-88. PubMed ID: 10950919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech outcome regarding overall intelligibility, articulation, resonance and voice in Flemish children a year after pharyngeal flap surgery. A pilot study.
    Van Lierde KM; Bonte K; Baudonck N; Van Cauwenberge P; De Leenheer EM
    Folia Phoniatr Logop; 2008; 60(5):223-32. PubMed ID: 18698142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between speech disorders and other clinical manifestations of Parkinson's disease].
    Seguier N; Spira A; Dordain M; Lazar P; Chevrie-Muller C
    Folia Phoniatr (Basel); 1974; 26(2):108-26. PubMed ID: 4845618
    [No Abstract]   [Full Text] [Related]  

  • 16. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
    Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
    Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speech treatment for Parkinson's disease.
    Ramig LO; Fox C; Sapir S
    Expert Rev Neurother; 2008 Feb; 8(2):297-309. PubMed ID: 18271714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease.
    Dias AE; Barbosa ER; Coracini K; Maia F; Marcolin MA; Fregni F
    Acta Neurol Scand; 2006 Feb; 113(2):92-9. PubMed ID: 16411969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.
    Kempler D; Van Lancker D
    Brain Lang; 2002 Mar; 80(3):449-64. PubMed ID: 11896652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.